Home
Tools
Resources
Blog
About

Search

Medicines Law & Policy Research and resources on intellectual property and health

Home
Tools
Resources
Blog
About

Tag: R&D

UN High-Level Panel on Access to Medicines calls for stronger public...

Ellen 't Hoen - September 15, 2016

Recent Posts

Dolutegravir Patent Licences Can Provide Access To All
“The diseases were in the South and the drugs were in the North”: Ellen ‘t Hoen speaks on video about the history and future of medicines and IP
The Most Common Misunderstanding about Compulsory Licensing
The Italian Exception – A personalised approach to accessing high-priced patented medicines

Posts by Subject

Access to Medicines Cancer competition law Compulsory licensing compulsory licensing for export Data exclusivity Delinkage dolutegravir European Union Gilead Hepatitis C HIV India Italy LDCs Medicines Patent Pool Orphan Drugs Patents R&D Sofosbuvir TRIPS flexibilities United Nations High Level Panel WHO WIPO WTO

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: info@medicineslawandpolicy.net.

This work is licensed under Creative Commons.